Christopher De Souza is a Director at Broadview Ventures in Boston and represents the fund as an Observer of the Board of Acesion Pharma. He started his pharmaceutical career at Novartis as senior scientist in the Metabolic and Cardiovascular Diseases group and then Director of Strategic Alliances. After Novartis, Christopher was VP of Business Development at SkyePharma US and also founded a business development consulting practice. He received an MBA from Rutgers University and a PhD in physiology from Louisiana State University. He completed his post-doctoral training at "The Upjohn Company" and the Joslin Diabetes Center/Harvard Medical School.
Pharmaceutical